The encyclopedia · Strategy & Leadership · Strategic decision · 1988–2020s
Softto: China's first listed beauty stock — blind diversification drove it to delist
China's first listed daily chemical stock went from ¥2.8B to delisting as the founder's diversification into real estate and pharma destroyed the core.
Softto Group (索芙特; stock 000662) · 2008
What happened
Softto was founded in 1988 by Liang Guojian, who built functional cosmetics — slimming soap, anti-hair-loss shampoo, papaya whitening face wash — that addressed specific consumer anxieties. The brand grew rapidly through celebrity endorsements (Jet Li, Louis Koo, Cecilia Cheung, Zhang Ziyi) and became a household name. In 2001 Softto completed a backdoor listing on the Shenzhen Stock Exchange, earning the title 'China's first daily chemical stock.' By 2006 it reached peak revenue of ¥1.26 billion and a market capitalization of ¥2.8 billion.
The decline began when Liang Guojian redirected the company's cash and energy into unrelated industries — real estate, pharmaceuticals, and other ventures far from Softto's core competence in cosmetics. The diversification consumed capital and management attention while the beauty business stagnated. Cumulative losses reached approximately ¥5 billion. By 2010 the company posted its first annual loss, and in 2012, after two consecutive loss years, the Shenzhen Stock Exchange designated the stock *ST索芙, its strongest warning before delisting.
To preserve the listing shell, Softto sold itself in 2015 to Teamax Technology, a smart-city company, for ¥4.1 billion, renaming to 天夏智慧 (Teamax Smart). The beauty business was spun off to Liang Guojian's holding company. The shell survived, but Teamax Smart itself later collapsed — its stock fell below ¥1 for 20 consecutive trading days and was delisted in February 2021, a 97.5% decline from its peak. His son Liang Yuhao revived the Softto brand and filed for a Nasdaq IPO in 2025 seeking $15 million, but it remained unprofitable with thinning revenue and a marginal market position.
Why it happened
- The founder treated Softto as a cash machine for unrelated bets — real estate and pharma — that consumed the capital and management attention the beauty business needed to survive.
- Functional cosmetics (slimming, whitening) were Softto's core differentiator, but the products relied on exaggerated claims that became untenable as Chinese advertising regulation tightened.
- The backdoor listing created a shell that was more valuable than the operating business — when the core weakened, preserving the shell became the priority over fixing the brand.
- The 2015 sale to Teamax Technology and pivot to smart city was a shell-preservation move that abandoned the beauty business, leaving it to family control without listed company resources.
The lesson
A successful brand is not a license to succeed in unrelated industries — Softto's founder treated the beauty business as a cash machine for real estate and pharma bets that ultimately consumed it.
Aftermath
Liang Guojian's son Liang Yuhao took over in 2019 and attempted to rebuild the brand through distribution reform, sub-brand expansion (isoftto, 达可舒, 清元), and online sales. It filed for a Nasdaq IPO in 2025 seeking $15 million, but was unprofitable with 2024 half-year revenue of just $5.5 million and a gross margin of 25.8% — below industry norms. The brand had no presence in major supermarket chains and its product range was thin. The former listed entity, 天夏智慧 (Teamax Smart), was delisted in 2021 after a financial scandal and sub-¥1 stock price.
Sources
- 界面新闻 — '二代接班后的索芙特谋求美股上市,它近三年均未盈利' (Apr 2025): Softto 2025 Nasdaq IPO attempt, recent financial data, second-generation succession, brand revival efforts
- Baidu search aggregate — Softto founding 1988, backdoor listing 2001, peak 2006 revenue ¥12.57亿, market cap ¥28亿, founder Liang Guojian, *ST索芙 designation 2012, sale to Teamax 2015, cumulative ¥50亿 losses, 97.5% stock decline
spotted an error? The club wants to know.
More like this
Marubi rode China's eye cream boom to a ¥92 stock — then brand aging cut it down to ¥19
Winona claimed 'fix acne in 28 days' live without the filing — Botanee fined twice
Colgate paid €1.5B for Filorga — then shut its China flagship 6 years later
Somewhere, someone solved the problem this company failed at. 2nd Opinion →

Comments · 0
Sign in to join the comments.